sentences:  For this reason, pharmaceutical companies concentrated on developing non-peptide NK1 receptor antagonists, and in 1991, three different companies revealed their first results.Since then, non-peptide NK1 receptor antagonists have been researched extensively and many structures and patents have appeared.Proposing the concept in the early 1990s, in 1998 Kramer, "et al.